NCT05137938: Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders)
- State
- Completed
- Phase
- No phase
- People
- 25 taking part
- Started
- 25 Oct 2021
- Primary completion
- 24 Jul 2023
- Arms
- Intranasal Ketamine (IN)
- Results
- None posted
- 25 Oct 2021: Trial started
- 30 Nov 2021: Trial registered
- 24 Jul 2023: Trial completed